Skip to main content
. 2023 Jan 10;13:1063002. doi: 10.3389/fimmu.2022.1063002

Figure 5.

Figure 5

Intact mass analyses. (A) The deconvoluted MW of the anti-EGFR/HER2 BsAb. (B) The deconvoluted MW of the anti-CD20/CD20 BsAb. MWs in red indicate the theoretical mass with C-terminal lysine clipping and MWs in blue indicate the observed mass. Anti-CD20 monospecific Ab (1) and anti-CD20 monospecific Ab (2) contain Fab corresponding to rituximab and obinutuzumab monoclonal antibodies, respectively.